GB754885A - Recovery of heparin - Google Patents

Recovery of heparin

Info

Publication number
GB754885A
GB754885A GB18577/54A GB1857754A GB754885A GB 754885 A GB754885 A GB 754885A GB 18577/54 A GB18577/54 A GB 18577/54A GB 1857754 A GB1857754 A GB 1857754A GB 754885 A GB754885 A GB 754885A
Authority
GB
United Kingdom
Prior art keywords
heparin
protein
solution
salt
precipitated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB18577/54A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB754885A publication Critical patent/GB754885A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Heparin is recovered from an alkaline or substantially neutral aqueous solution containing also a protein by adding a soluble salt of an alkali metal, or of ammonium, or of an alkaline earth metal to said solution, acidifying the solution to precipitate the protein, removing the protein and recovering the heparin from the remaining solution. The solution of the proteinheparin mixture may have a pH between 7 and 10. Sufficient soluble salt may be added to produce an anion concentration of at least about one mol. per litre. Suitable salts which may be used are alkali metal and ammonium citrates, halides, acetates, sulphates and thiocyanates, and alkaline earth metal halides, acetates and citrates, e.g. sodium chloride, sodium thiocyante, calcium chloride and acetate, and ammonium sulphate and citrate may be used. When sodium chloride is used, the solution may be acidified to a pH of less than 4, e.g. when between about 100 grams and about 150 grams of sodium chloride is used, the solution may be acidified to a pH of about 2.5 to precipitate the protein. The heparin solution containing protein may be obtained by autolyzing heparinbearing animal tissue, extracting the autolyzed tissue with an aqueous solution of alkali, e.g. ammonium sulphate and sodium hydroxide, heating the mixture, filtering to remove the coagulated substance, acidifying to precipitate a protein-heparin complex which is dissolved in water at a pH of at least 7 to form the solution for the above process. The process is applicable to heparin mixtures containing denatured or native proteins. The temperature at which protein coagulation is effected may vary from about 0 DEG C. to about 100 DEG C.-heating during or after the acidification being particularly useful. Suitable acids which may be used for the acidification are strong inorganic and strong organic acids such as sulphuric, hydrochloric and trichloroacetic acids. The heparin is preferably precipitated from the protein-free solution by adding a water-miscible organic solvent such as methyl or ethyl alcohol or acetone. When the soluble salt used in the above process is not very soluble in ethyl alcohol or acetone, it is desirable to subject the filtrate to dialysis to remove the salt before the heparin is precipitated. Alternatively, the precipitated heparin containing the salt may be dissolved in water, the solution subjected to dialysis to remove the salt, and reprecipitating the heparin with alcohol or acetone. The process is suitable for the purification of heparin, e.g. impure heparin can be mixed with an acid precipitable protein such as casein, the mixture is acidified and the resulting precipitated heparin-protein complex can then be treated by the above process. A number of detailed examples are given. U.S.A. Specification 2,623,001 is referred to.
GB18577/54A 1953-07-01 1954-06-24 Recovery of heparin Expired GB754885A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US754885XA 1953-07-01 1953-07-01

Publications (1)

Publication Number Publication Date
GB754885A true GB754885A (en) 1956-08-15

Family

ID=22126091

Family Applications (1)

Application Number Title Priority Date Filing Date
GB18577/54A Expired GB754885A (en) 1953-07-01 1954-06-24 Recovery of heparin

Country Status (1)

Country Link
GB (1) GB754885A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105399865A (en) * 2014-09-16 2016-03-16 东营天东制药有限公司 Efficient heparin sodium bulk drug refining process
CN115286725A (en) * 2022-08-31 2022-11-04 山东万邦赛诺康生化制药股份有限公司 Preparation method of high-purity low-molecular-weight heparin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105399865A (en) * 2014-09-16 2016-03-16 东营天东制药有限公司 Efficient heparin sodium bulk drug refining process
CN115286725A (en) * 2022-08-31 2022-11-04 山东万邦赛诺康生化制药股份有限公司 Preparation method of high-purity low-molecular-weight heparin

Similar Documents

Publication Publication Date Title
CN109096161B (en) Preparation method of N-acetylcysteine
US3936375A (en) Process for dewatering a proteinaceous, aqueous sludge and for removing and recovering precipitating agents from a precipitate containing proteinaceous substances
GB754885A (en) Recovery of heparin
US2710858A (en) Making ferrilactin
US3936351A (en) Method for preparing glucoronyl-glucosamino-glycan sulphates exhibiting antilipasaemic activity
US2797184A (en) Process for the recovery of heparin
US3518243A (en) Sulfonated derivatives of a glycopeptide extracted from animal organs,useful as drugs and a process for the preparation thereof
US2009868A (en) Method of preparing leucine
US2598341A (en) Manufacture of protein hydrolysates
US2549526A (en) Process for recovery of vegetable protein
US2243871A (en) Method of making protein products
CA1054896A (en) Process for removing and recovering precipitation agents from precipitate containing proteinous substances
FI65073B (en) FOERFARANDE FOER FRAMSTAELLNING AV HEPARIN
GB751287A (en) Improvements in or relating to process of preparing amino acids
GB1480857A (en) Production of protein isolates
US2379912A (en) Nucleic acid
SU531476A3 (en) The method of obtaining albumin and whey proteins
GB872214A (en) Extraction process for the recovery of heparin
GB816281A (en) Coagulation of lignin in aqueous suspension
Robson et al. A new technique for the estimation and isolation of the hexone bases in protein hydrolysates
GB906819A (en) Parenteral solution for diagnostic test of cancer and a process of preparing same
SU406544A1 (en) METHOD OF OBTAINING GLOBIN
GB1239861A (en) Improvements in or relating to the production of collagen and/or gelatine
US2723291A (en) Treatment of glutamic acid-containing hydrolysates
US2758055A (en) Recovery of enzymes from pancreas gland residues subsequent to insulin removal